These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 15898611

  • 21. [New research results give hope. Causal therapy of Crohn disease in sight].
    MMW Fortschr Med; 2004 Apr 01; 146(14):42-3. PubMed ID: 15344754
    [No Abstract] [Full Text] [Related]

  • 22. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M.
    Ther Drug Monit; 2007 Feb 01; 29(1):1-5. PubMed ID: 17304143
    [Abstract] [Full Text] [Related]

  • 23. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
    Rutgeerts P.
    Gut; 2001 Apr 01; 48(4):452-3. PubMed ID: 11247886
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Myocarditis by mesalazine with cardiac magnetic resonance imaging.
    García-Ferrer L, Estornell J, Palanca V.
    Eur Heart J; 2009 Apr 01; 30(8):1015. PubMed ID: 19168869
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [A case of Crohn's disease that shows the improvement of the gastric disorder by the administration of mesalazine powder].
    Nagamata H, Torii A, Izumi M, Anami M, Yamashita N, Inadama E, Toda G.
    Nihon Shokakibyo Gakkai Zasshi; 2000 Oct 01; 97(10):1261-6. PubMed ID: 11075590
    [No Abstract] [Full Text] [Related]

  • 32. [Inflammatory diseases of the intestines].
    Felley C, Guyot J, Hess J, Mottet C, Delarive J, Michetti P.
    Rev Med Suisse; 2006 Jan 18; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
    [Abstract] [Full Text] [Related]

  • 33. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P, Pérez Roldán F, Roncero García Escribano O, Lafuente R, Legaz Huidobro ML, Amigo Echenagusía A.
    J Clin Apher; 2006 Dec 18; 21(4):249-51. PubMed ID: 16607627
    [No Abstract] [Full Text] [Related]

  • 34. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
    Neĭman KP, Rumiantsev VG.
    Eksp Klin Gastroenterol; 2006 Dec 18; (3):56-60. PubMed ID: 17203844
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Can the postoperative relapse of Crohn disease be influenced?].
    Jussila A, Färkkilä M, Järvinen HJ.
    Duodecim; 2001 Dec 18; 117(8):817-22; quiz 822, 857. PubMed ID: 12116447
    [No Abstract] [Full Text] [Related]

  • 39. Mesalazine-induced Churg-Strauss syndrome in a patient with Crohn's disease and sclerosing cholangitis.
    Sinico RA, Sabadini E, Maresca AM.
    Clin Exp Rheumatol; 2006 Dec 18; 24(2 Suppl 41):S104. PubMed ID: 16859609
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.